A ruling against skinny labeling could push back generic drug competition by years, with billions in costs passed on to ...

In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

Can a generic manufacturer compare its product to the branded competitor?

The Supreme Court Wednesday will hear oral arguments about a simmering controversy over so-called skinny labels, with ...

Supreme Court justices on Wednesday will hear arguments in a patent case that could change the way generic drug companies ...

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

The Dr. Reddy's medication is the first generic semaglutide authorized by Health Canada. Health Canada noted that it completed the review of Dr. Reddy's submission within its target timeline of 180 ...

The settlements delay the entry of generic copies of Pfizer’s Vyndamax by almost three years, stabilizing sales of a drug ...

The US Food and Drug Administration (FDA) approved or tentatively approved 776 Abbreviated New Drug Applications (ANDAs) for generic drugs in 2021, continuing a steady decline in generic approvals in ...

Officials with the FDA have approved a generic moxidectin product for the treatment and control of internal parasites in ...